Cost minimization analysis of the different combinations of nucleoside analog reverse transcriptase inhibitors associated with adverse events in HIV-1 infected patients

  1. Moreno, S.
  2. Casado, M.Á.
  3. Domingo, P.
  4. Llibre, J.M.
  5. Martínez, E.
  6. Miralles, C.
  7. Santos, J.
  8. Pérez-Elías, M.J.
  9. Herrera, L.
  10. Sánchez-De La Rosa, R.
Revista:
Pharmacoeconomics - Spanish Research Articles

ISSN: 1695-405X

Ano de publicación: 2007

Volume: 4

Número: 1

Páxinas: 25-36

Tipo: Artigo

DOI: 10.1007/BF03323428 GOOGLE SCHOLAR